Exicure agrees to sell GPC-100 program assets to GPCRT for KRW 6.5 billion

• Exicure agreed Nov. 4, 2026, to sell its GPC-100 program assets to GPCRT for KRW 6.5 billion (approximately USD 4.8 million).
• GPCRT previously paid KRW 500 million; KRW 2 billion is due Nov. 16, 2026, with KRW 4 billion payable at closing.
• GPCRT will assume future milestone and royalty obligations at closing, bearing program costs incurred from Sept. 1, 2026.
• GPCR USA will remain a wholly owned subsidiary; the seller retains other liabilities, including program liabilities incurred before Sept. 1, 2026.
• Closing requires approvals, third-party consents and a waiver from GPCR Therapeutics, including shareholder approval if required.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exicure Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611101550PRIMZONEFULLFEED9874835) on November 10, 2026, and is solely responsible for the information contained therein.